We could not find any results for:
Make sure your spelling is correct or try broadening your search.
MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple scleros... MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. Show more
MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company committed to developing novel therapies for age-related diseases, autoimmune and...
Common Stock Will Begin Trading on Split-Adjusted Basis on February 15, 2024 MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage biopharmaceutical company...
Company targets first quarter 2024 for trial initiation Potential to be first orally-administered TNF-α inhibitor treatment for RA MyMD Pharmaceuticals, Inc.® (Nasdaq: MYMD) (“MyMD” or “the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.34 | 13.6 | 2.5 | 2.9324 | 2.5 | 46174 | 2.71822983 | CS |
4 | 0.44 | 18.3333333333 | 2.4 | 3.5 | 2 | 651045 | 2.60996111 | CS |
12 | -1.51 | -34.7126436782 | 4.35 | 4.5 | 2 | 428547 | 3.2680407 | CS |
26 | -9.847 | -77.6148813746 | 12.687 | 12.903 | 2 | 977275 | 6.66134047 | CS |
52 | -54.16 | -95.0175438596 | 57 | 70.5 | 2 | 818392 | 18.38677704 | CS |
156 | -120.76 | -97.7022653722 | 123.6 | 298.5 | 2 | 419780 | 53.06724827 | CS |
260 | -160.06 | -98.2565991406 | 162.9 | 298.5 | 2 | 438322 | 57.6189647 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions